Baseline PSMA PET-CT is prognostic for treatment failure in men with intermediate-to-high risk prostate cancer: 54 months follow-up of the proPSMA randomised trial

V Kasivisvanathan, D. G. Murphy,E. Link,N. Lawrentschuk,J. O'Brien,J. P. Buteau,M. Roberts,R. J. Francis, C. Tang,I Vela, P. Thomas, N. Rutherford,J. Martin,M. Frydenberg, R. Shakher, L-M Wong,K. Taubman,S. T. Lee,E. Hsiao, M. Nottage, I Kirkwood, A. Iravani,S. Williams, M. S. Hofman

European Urology(2023)

引用 0|浏览36
暂无评分
关键词
prostate cancer,treatment failure,intermediate-to-high
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要